Clinical Trials Sponsored by Myeloid Therapeutics
Total 6354 results
-
Myeloid TherapeuticsSuspendedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Lymphoma, T-Cell, Peripheral | Cell Therapy | Adoptive Cellular ImmunotherapyUnited States
-
Myeloid TherapeuticsRecruitingEpithelial Tumors, MalignantAustralia
-
Myelo Therapeutics GmbHCompletedBreast Cancer | Myelosuppression | Chemotherapy-Induced NeutropeniaGermany
-
European Myeloma NetworkKaryopharm Therapeutics IncRecruitingMultiple MyelomaSpain, United States, Germany, Netherlands, Greece, France, Italy
-
University of LeedsKaryopharm Therapeutics Inc; Myeloma UKWithdrawnMyeloma MultipleUnited Kingdom
-
Stichting Hemato-Oncologie voor Volwassenen NederlandEuropean Myeloma Network; Gruppo Italiano Malattie EMatologiche dell'Adulto; DSMM... and other collaboratorsActive, not recruitingMultiple MyelomaSweden, Norway, Italy, Netherlands, Belgium, Switzerland, Australia, Denmark, Finland, Czechia, Turkey, Austria, Luxembourg, Hungary, Greece, Portugal
-
European Myeloma NetworkCompletedAL AmyloidosisNetherlands, Czechia, Austria, France, Germany, Greece, Italy, Portugal, Spain, United Kingdom
-
European Myeloma NetworkCompletedMultiple Myeloma | Hematologic MalignanciesSpain, Sweden, Germany, Italy
-
European Myeloma NetworkCompleted
-
Intergroupe Francophone du MyelomeRecruiting
-
Intergroupe Francophone du MyelomeTerminatedCovid19 | Multiple MyelomaFrance
-
Multiple Myeloma Research FoundationActive, not recruiting
-
Canadian Myeloma Research GroupCompletedMultiple Myeloma in RelapseCanada
-
Intergroupe Francophone du MyelomeCompleted
-
Intergroupe Francophone du MyelomeCompletedMultiple Myeloma | Blood Stem Cell Transplant FailureFrance
-
Nordic Myeloma Study GroupCompletedMultiple MyelomaDenmark, Sweden, Norway
-
European Myeloma NetworkPfizerNot yet recruitingSmoldering Multiple MyelomaNetherlands, Finland, Norway, France, Italy, Greece
-
Multiple Myeloma Research FoundationTerminated
-
Canadian Myeloma Research GroupActive, not recruiting
-
Canadian Myeloma Research GroupCompleted
-
Intergroupe Francophone du MyelomeUnknown
-
Ranok Therapeutics (Hangzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | DLBCLUnited States
-
Multiple Myeloma Research ConsortiumNot yet recruitingRefractory Multiple Myeloma | Relapse Multiple Myeloma
-
Canadian Myeloma Research GroupNot yet recruiting
-
European Myeloma NetworkGlaxoSmithKlineRecruitingAL AmyloidosisGermany, Netherlands, France, Greece, Italy, United Kingdom
-
Intergroupe Francophone du MyelomeActive, not recruitingSmoldering Multiple MyelomaFrance, Belgium, Monaco
-
Intergroupe Francophone du MyelomeCompleted
-
Nordic Myeloma Study GroupUnknownMultiple MyelomaDenmark
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
European Myeloma NetworkJanssen, LPActive, not recruitingMultiple Myeloma | Extramedullary PlasmacytomaTurkey, Italy, Greece
-
AmgenMultiple Myeloma Research FoundationApproved for marketing
-
European Myeloma NetworkJanssen PharmaceuticaActive, not recruitingLight Chain (AL) Amyloidosis, Stage 3BNetherlands, Greece, France, Italy
-
Akebia TherapeuticsCyclerion TherapeuticsCompletedType 2 Diabetes Mellitus With Diabetic NephropathyUnited States
-
Akebia TherapeuticsCyclerion TherapeuticsCompletedHeart Failure With Preserved Ejection FractionUnited States, Canada
-
European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaUnited Kingdom, Czechia, Australia, Austria, Belgium, Denmark, Germany, Greece, Italy, Netherlands, Norway, Serbia, Switzerland, Turkey, Brazil
-
CelgeneMultiple Myeloma Research ConsortiumCompleted
-
Eikon TherapeuticsImpact Therapeutics, Inc.RecruitingAdvanced Solid TumorAustralia, United States
-
APRINOIA Therapeutics, LLCActive, not recruitingAlzheimer Disease | Tauopathies | Healthy VolunteersUnited States
-
CRISPR Therapeutics AGActive, not recruitingRenal Cell CarcinomaUnited States, Australia, Canada, Netherlands
-
Stichting European Myeloma NetworkJanssen, LPRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | Plasma Cell Leukemia | MGUS | Extramedullary MyelomaItaly, Austria, Czechia, Greece, Serbia
-
CRISPR Therapeutics AGRecruitingClear Cell Renal Cell Carcinoma | Pancreatic Adenocarcinoma | Cervical Carcinoma | Malignant Pleural Mesothelioma | Esophageal CarcinomaUnited States
-
CRISPR Therapeutics AGActive, not recruitingT Cell LymphomaUnited States, Australia, Canada
-
CRISPR Therapeutics AGActive, not recruitingB-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALLUnited States, Spain, Canada, France, Germany, Australia
-
Bacainn Therapeutics, Inc.CompletedHealthy VolunteersUnited States
-
Celsus Therapeutics PLCTerminatedAtopic DermatitisIsrael
-
CRISPR Therapeutics AGRecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Large B-cell Lymphoma | Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)United States
-
CRISPR Therapeutics AGEnrolling by invitationHematologic Malignancy | Solid MalignancyUnited States
-
CRISPR Therapeutics AGActive, not recruitingMultiple MyelomaUnited States, Spain, Australia, Canada
-
APRINOIA Therapeutics, LLCActive, not recruitingHealthy Volunteers | Alzheimer's Disease | Mild Cognitive Impairment Due to Alzheimer's DiseaseUnited States
-
University of LeedsCelgene; Myeloma UKActive, not recruitingMultiple MyelomaUnited Kingdom